Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.

@article{Siristatidis2013ControlledOH,
  title={Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.},
  author={Charalampos Siristatidis and Theodoros N. Sergentanis and Prodromos Kanavidis and Maria Giovanna Trivella and Marianthi Sotiraki and Ioannis Mavromatis and Theodora Psaltopoulou and Alkistis Skalkidou and Eleni Th. Petridou},
  journal={Human reproduction update},
  year={2013},
  volume={19 2},
  pages={
          105-23
        }
}
BACKGROUND In response to the ongoing debate on the long-term effects of assisted reproduction technologies, such as IVF, we systematically reviewed and meta-analyzed available evidence on the association between controlled ovarian hyperstimulation for IVF and risk of ovarian, endometrial and cervical cancer. METHODS Eligible studies were identified and pooled effect estimates for relative risk (RR) were calculated by cancer type among two reference groups (general population or infertile… 

Figures and Tables from this paper

IVF and breast cancer: a systematic review and meta-analysis.

TLDR
At present, COH for IVF does not seem to impart increased breast cancer risk, but longer follow-up periods, comparisons versus infertile women, subgroup analyses aiming to trace vulnerable subgroups, adjustment for various confounders and larger informative data sets are needed before conclusive statements for the safety of the procedure are reached.

Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

TLDR
There was no convincing evidence of an increase in the risk of invasive ovarian tumours with fertility drug treatment in women treated with ovulation stimulating drugs for subfertile women.

Impact of infertility and assisted reproductive technology on cancer risk

TLDR
It is suggested that infertile women have a higher risk of ovarian and endometrial cancer, but not breast cancer, and the possible increase in ovarian tumor risk following ART treatments needs to be investigated further.

Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

TLDR
There was no increase in risk of invasive ovarian cancer after use of infertility drugs in women with the BRCA mutation according to one cohort and one case-control study, and the certainty of evidence as assessed using GRADE was very low.

Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors.

TLDR
Women can be reassured that fertility drugs do not appear to significantly increase the risk of invasive ovarian, endometrial, breast or other cancers, while achieving a pregnancy at an earlier age is a significant protective factor.

Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis.

TLDR
Overall, FT does not significantly increase the incidence of breast, ovarian or endometrial cancer and may even reduce the incidence in no-FT groups and the results are reassuring.

Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.

TLDR
The quality of evidence was very low, due to serious risk of bias and indirectness, and the association between the use of ovary-stimulating drugs for the treatment of subfertility and the risk of endometrial cancer was not evaluated.

A Potential Pathogenic Link Between Cancer of Female Reproductive System and Infertile Women Treated With Assisted Reproduction Techniques

TLDR
The objective of this review is to summarize the latest data of ovarian hyperstimulation and IVF, associated with the risk of gynecological tract cancer development.

Assisted reproductive technology and uterine cancer risk. A systematic review and meta-analysis

TLDR
A systematic review and meta-analysis of studies on the possible relationship of uterine cancer and assisted reproductive technology methods published to date demonstrated the ambiguity of the design and results of studies.
...

References

SHOWING 1-10 OF 188 REFERENCES

Induction of ovulation and ovarian cancer: a critical review of the literature.

Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

TLDR
Data suggest a role for specific biologic causes of infertility, but not for fertility drugs in overall risk for ovarian cancer, as suggested in case-control studies conducted between 1989 and 1999.

A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.

TLDR
The hypothesis that a subset of nulliparous women who experience infertility may be at increased risk of ovarian cancer is supported, and the reasons for this increase in risk remain unclear.

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

Cancer morbidity in a cohort of 9175 Finnish women treated for infertility.

TLDR
General cancer risk or risk of hormonal-related cancers in women was not increased by IVF, and differences in certain cancers suggest a healthy patient effect or may be partly caused by residual socio-economic differences.

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort

TLDR
Findings do not support strong associations between ovulation-stimulation drugs and cancer risks, but they indicate the need for continued monitoring to establish whether risks are elevated in certain subgroups of users.

Ovarian Stimulation: Is There a Long-Term Risk for Ovarian, Breast and Endometrial Cancer?

TLDR
While results regarding the possible association of infertility, ovulation induction medications and invasive ovarian cancer show no increased risk and are reassuring, results for increased risk for breast cancer and endometrial cancer following exposure to ovarian stimulation medications are inconclusive.

Cancer incidence in a cohort of infertile women who underwent in vitro fertilization.

...